| High Desert Language And Learning, Llc | |
|
1010 Milda St, Gallup, NM 87301-7022 | |
| (505) 722-2844 | |
| (505) 863-3964 |
| Full Name | High Desert Language And Learning, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 1010 Milda St, Gallup, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659599215 | NPI | - | NPPES |
| 03050889000 | Other | NM | CRS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2879 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| High Desert Language And Learning, Llc 1010 Milda St, Gallup, NM 87301-7022 Ph: (505) 722-2844 | High Desert Language And Learning, Llc 1010 Milda St, Gallup, NM 87301-7022 Ph: (505) 722-2844 |
News Archive
Purdue Pharma L.P. of Stamford, Connecticut and Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania have agreed to end their lawsuit concerning certain Purdue Pharma patents on OxyContin (oxycodone HCl controlled-release) Tablets.
Regions of Italy with higher family fragmentation and a high number of residential nursing homes experienced the highest rate of COVID-19 infections in people over age 80, according to a new study published May 21, 2020 in the open-access journal PLOS ONE by Giuseppe Liotta of the University of Rome, Italy, and colleagues.
Vitamin D deficiency from birth to early childhood was associated with an increased risk of elevated blood pressure in later childhood and adolescence, according to new research in the American Heart Association journal Hypertension.
A new report calls for measures to protect elderly people in long-term care facilities and their caregivers who are particularly vulnerable to the COVID-19 pandemic.
Genentech, Inc. has announced that both study arms of a randomized, multi-center Phase II clinical study of Avastin (bevacizumab) administered alone or in combination with irinotecan chemotherapy demonstrated encouraging six-month progression-free survival (PFS) and objective response rate in patients with relapsed glioblastoma multiforme (GBM), the most common and aggressive type of brain cancer.
› Verified 8 days ago
Katelyn Anne Ferguson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-721-1807 Fax: 505-721-1899 | |
Jeffrey Curnett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-721-1806 | |
Kendra Leigh Kennedy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-721-1800 | |
Brenda D. Rosebrough, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-721-1877 | |
Ms. Brenda Lee Machain, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-721-1800 Fax: 505-721-1899 | |
Darlene Crofcheck Cherney, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-879-0866 | |
Ms. Sean Lawhorn, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 516 E Nizhoni Blvd, Gallup, NM 87301 Phone: 505-722-1402 Fax: 505-722-1771 |